Inogen Inc (INGN) - Total Liabilities

Latest as of September 2025: $109.83 Million USD

Based on the latest financial reports, Inogen Inc (INGN) has total liabilities worth $109.83 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Inogen Inc (INGN) cash flow conversion to assess how effectively this company generates cash.

Inogen Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how Inogen Inc's total liabilities have evolved over time, based on quarterly financial data. Check Inogen Inc (INGN) asset resilience to evaluate the company's liquid asset resilience ratio.

Inogen Inc Competitors by Total Liabilities

The table below lists competitors of Inogen Inc ranked by their total liabilities.

Company Country Total Liabilities
JADESTONE ENERGY LS -001
F:8KW
Germany €1.06 Billion
Havilah Resources Ltd
AU:HAV
Australia AU$1.77 Million
China Harmony Auto Holding Limited
F:HA5
Germany €6.61 Billion
ABL Group ASA
OL:ABL
Norway Nkr114.59 Million
Coastal Contracts Bhd
KLSE:5071
Malaysia RM62.42 Million
LaFayette Acquisition Corp. Ordinary Share
NASDAQ:LAFA
USA $340.23K
E-Life Mall Corp
TW:6281
Taiwan NT$6.29 Billion
Punjab Chemicals & Crop Protection Limited
NSE:PUNJABCHEM
India Rs2.93 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Inogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INGN market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.56 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.36 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Inogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Inogen Inc (2011–2024)

The table below shows the annual total liabilities of Inogen Inc from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 $122.33 Million +0.78%
2023-12-31 $121.38 Million +12.77%
2022-12-31 $107.64 Million -9.77%
2021-12-31 $119.29 Million +6.29%
2020-12-31 $112.23 Million +9.26%
2019-12-31 $102.72 Million +56.88%
2018-12-31 $65.47 Million +36.32%
2017-12-31 $48.03 Million +50.28%
2016-12-31 $31.96 Million +17.09%
2015-12-31 $27.30 Million +24.44%
2014-12-31 $21.93 Million -15.95%
2013-12-31 $26.10 Million +37.28%
2012-12-31 $19.01 Million +14.70%
2011-12-31 $16.57 Million --

About Inogen Inc

NASDAQ:INGN USA Medical Devices
Market Cap
$189.50 Million
Market Cap Rank
#17481 Global
#3930 in USA
Share Price
$6.98
Change (1 day)
-1.83%
52-Week Range
$5.59 - $8.95
All Time High
$282.92
About

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term ox… Read more